Chemoinformaics analysis of 2-Hydroxy-3-methyl-1,4-naphthoquinone
| Molecular Weight | 188.182 | nRot | 0 |
| Heavy Atom Molecular Weight | 180.118 | nRig | 14 |
| Exact Molecular Weight | 188.047 | nRing | 2 |
| Solubility: LogS | -3.583 | nHRing | 0 |
| Solubility: LogP | 1.657 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 26.1103 |
| nHD | 1 | BPOL | 9.76166 |
| QED | 0.455 |
| Synth | 2.673 |
| Natural Product Likeliness | 0.415 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.033 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.554 |
| MDCK | 0.0000288 |
| BBB | 0.369 |
| PPB | 0.944771 |
| VDSS | 0.412 |
| FU | 0.012834 |
| CYP1A2-inh | 0.938 |
| CYP1A2-sub | 0.635 |
| CYP2c19-inh | 0.401 |
| CYP2c19-sub | 0.162 |
| CYP2c9-inh | 0.253 |
| CYP2c9-sub | 0.351 |
| CYP2d6-inh | 0.125 |
| CYP2d6-sub | 0.275 |
| CYP3a4-inh | 0.064 |
| CYP3a4-sub | 0.196 |
| CL | 1.547 |
| T12 | 0.238 |
| hERG | 0.011 |
| Ames | 0.731 |
| ROA | 0.194 |
| SkinSen | 0.348 |
| Carcinogencity | 0.553 |
| EI | 0.275 |
| Respiratory | 0.201 |
| NR-Aromatase | 0.03 |
| Antiviral | No |
| Prediction | 0.640358 |